Home › Funds › SUSQUEHANNA ADVISORS GROUP, INC. › LGND
SUSQUEHANNA ADVISORS GROUP, INC. position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
SUSQUEHANNA ADVISORS GROUP, INC. reported holding 44,600 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$14.1M, representing 0.35% of its reported portfolio and ranking #39 among its reported holdings. SUSQUEHANNA ADVISORS GROUP, INC. first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUSQUEHANNA ADVISORS GROUP, INC.'s LGND position evolved
SUSQUEHANNA ADVISORS GROUP, INC. first disclosed a stake in LGND in Q2 2026 at 44,600 shares (US$14.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 44.60K | $14.10M | New |
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 58 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$150.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 475.61K sh · $150.34M · Q2 2026
- RICE HALL JAMES & ASSOCIATES, LLC 270.05K sh · $85.36M · Q2 2026
- Ranger Investment Management, L.P. 257.60K sh · $81.42M · Q2 2026
- GW&K Investment Management, LLC 246.88K sh · $78.04M · Q2 2026
- NEXT CENTURY GROWTH INVESTORS LLC 198.54K sh · $62.76M · Q2 2026
- ASHFORD CAPITAL MANAGEMENT INC 170.24K sh · $53.81M · Q2 2026
- Private Capital Management, LLC 166.02K sh · $52.48M · Q2 2026
- VILLERE ST DENIS J & CO LLC 155.51K sh · $49.15M · Q2 2026
- Granahan Investment Management, LLC 147.23K sh · $46.54M · Q2 2026
- Penn Capital Management Company, LLC 100.34K sh · $31.75M · Q2 2026
More on SUSQUEHANNA ADVISORS GROUP, INC.
FAQ
How long has SUSQUEHANNA ADVISORS GROUP, INC. held LGND?
SUSQUEHANNA ADVISORS GROUP, INC. has disclosed LGND holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is SUSQUEHANNA ADVISORS GROUP, INC.'s current position in LGND?
As of Q2 2026, SUSQUEHANNA ADVISORS GROUP, INC. holds 44.60K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $14.10M, representing 0.35% of its reported portfolio and ranking #39.
Has SUSQUEHANNA ADVISORS GROUP, INC. been buying or selling LGND?
In the latest 13F filing (Q2 2026), SUSQUEHANNA ADVISORS GROUP, INC. newly opened its position in LGND.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.